Equine Coagulopathies

Veterinary Clinics of North America - Equine Practice

Volumn 24, Issue 2, 2008, Pages 335-355

  Brooks, Marjory B ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; BLEEDING; BLOOD; BLOOD CLOTTING DISORDER; BLOOD EXAMINATION; DIFFERENTIAL DIAGNOSIS; HEMOSTASIS; HORSE; HORSE DISEASE; METHODOLOGY; REVIEW; STANDARD;

ANIMALS; BLOOD COAGULATION DISORDERS; DIAGNOSIS, DIFFERENTIAL; HEMATOLOGIC TESTS; HEMORRHAGE; HEMOSTASIS; HORSE DISEASES; HORSES;

EQUIDAE;

EID: 47349121657     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2008.05.001     Document Type: Review

References (89)

1. Roberts H.R., Hoffman M., and Monroe D.M. A cell-based model of thrombin generation. Semin Thromb Hemost 32 Suppl 1 (2006) 32-38
2. Monroe D.M., and Hoffman M. What does it take to make the perfect clot?. Arterioscler Thromb Vasc Biol 26 1 (2006) 41-48
3. Esmon C.T. Coagulation inhibitors in inflammation. Biochem Soc Trans 33 Pt 2 (2005) 401-405
4. Rau J.C., Beaulieu L.M., Huntington J.A., et al. Serpins in thrombosis, hemostasis and fibrinolysis. J Thromb Haemost 5 Suppl 1 (2007) 102-115
5. Hertfelder H.J., Bos M., Weber D., et al. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting. Semin Thromb Hemost 31 4 (2005) 426-440
6. Kohtz R.J., Stammers A.H., Mills N.J., et al. Expanding perfusion services through mobile point-of-care coagulation monitoring. J Extra Corpor Technol 34 3 (2002) 190-196
7. Dallap B.L. Coagulopathy in the equine critical care patient. Vet Clin North Am Equine Pract 20 1 (2004) 231-251
8. Segura D., Monreal L., Espada Y., et al. Assessment of a platelet function analyser in horses: reference range and influence of a platelet aggregation inhibitor. Vet J 170 1 (2005) 108-112
9. Tasker S., Cripps P.J., and Mackin A.J. Estimation of platelet counts on feline blood smears. Vet Clin Pathol 28 (1999) 42-45
10. Hinchcliff K.W., Kociba G.J., and Mitten L.A. Diagnosis of EDTA-dependent pseudothrombocytopenia in a horse. J Am Vet Med Assoc 203 12 (1993) 1715-1716
11. Shah U., and Ma A.D. Tests of platelet function. Curr Opin Hematol 14 5 (2007) 432-437
12. Kopp K.J., Moore J.N., Byars T.D., et al. Template bleeding time and thromboxane generation in the horse: effects of three non-steroidal anti-inflammatory drugs. Equine Vet J 17 4 (1985) 322-324
13. Segura D., Monreal L., Perez-Pujol S., et al. Assessment of platelet function in horses: ultrastructure, flow cytometry, and perfusion techniques. J Vet Intern Med 20 3 (2006) 581-588
14. Norris J.W., Pratt S.M., Auh J.H., et al. Investigation of a novel, heritable bleeding diathesis of Thoroughbred horses and development of a screening assay. J Vet Intern Med 20 6 (2006) 1450-1456
15. Livesey L., Christopherson P., Hammond A., et al. Platelet dysfunction (Glanzmann's thrombasthenia) in horses. J Vet Intern Med 19 6 (2005) 917-919
16. Brooks M., and Catalfamo J. Buccal mucosa bleeding time is prolonged in canine models of primary hemostatic disorders. Thromb Haemost 70 5 (1993) 777-780
17. Jilma B. Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 138 (2001) 152-163
18. Benson R.E., Catalfamo J.L., and Dodds W.J. A multispecies enzyme-linked immunosorbent assay for von Willebrand's factor. J Lab Clin Med 119 4 (1992) 420-427
19. Brooks M., Leith G.S., Allen A.K., et al. Bleeding disorder (von Willebrand disease) in a quarter horse. J Am Vet Med Assoc 198 1 (1991) 114-116
20. Triplett D.A. Coagulation and bleeding disorders: review and update. Clin Chem 46 8 Pt 2 (2000) 1260-1269
21. Federici A.B. Diagnosis of inherited von Willebrand disease: a clinical perspective. Semin Thromb Hemost 32 6 (2006) 555-565
22. Meinkoth J.H., and Allison R.W. Sample collection and handling: getting accurate results. Vet Clin North Am Small Anim Pract 37 2 (2007) 203-219 v
23. Lippi G., Franchini M., Montagnana M., et al. Quality and reliability of routine coagulation testing: can we trust that sample?. Blood Coagul Fibrinolysis 17 7 (2006) 513-519
24. Karges H.E., Funk K.A., and Ronneberger H. Activity of coagulation and fibrinolysis parameters in animals. Arzneimittelforschung 44 6 (1994) 793-797
25. Topper M.J., and Prasse K.W. Analysis of coagulation proteins as acute-phase reactants in horses with colic. Am J Vet Res 59 5 (1998) 542-545
26. Topper M.J., and Prasse K.W. Chromogenic assays for equine coagulation factors VII, VIII:C, IX, and X, and C1-esterase inhibitor. Am J Vet Res 59 5 (1998) 538-541
27. Stokol T., Erb H.N., De Wilde L., et al. Evaluation of latex agglutination kits for detection of fibrin(ogen) degradation products and D-dimer in healthy horses and horses with severe colic. Vet Clin Pathol 34 4 (2005) 375-382
28. Dodds W.J. Hemostasis. In: JJ K., JW H., and ML B. (Eds). Clinical biochemistry of domestic animals. 5th edition (1997), Academic Press, San Diego 241-284
29. Gerber B., Taboada J., Lothrop Jr. C.D., et al. Determination of normal values using an automated coagulation timer for activated coagulation time and its application in dogs with hemophilia. J Vet Intern Med 13 5 (1999) 433-436
30. Rawlings C.A., Byars T.D., Van Noy M.K., et al. Activated coagulation test in normal and heparinized ponies and horses. Am J Vet Res 36 5 (1975) 711-713
31. Triplett D.A., and Smith M.T. Routine testing in the coagulation laboratory. In: Triplett D.A. (Ed). Laboratory evaluation of coagulation (1982), American Society of Clinical Pathology Press, Indiana 27-52
32. Brooks M.B. Coagulopathies and thrombosis. In: Ettinger S.J., and Feldman B.F. (Eds). Textbook of veterinary internal medicine. 5th edition (2000), W.B. Saunders, Co, Philadelphia 1829-1841
33. Roemisch J., Gray E., Hoffmann J.N., et al. Antithrombin: a new look at the actions of a serine protease inhibitor. Blood Coagul Fibrinolysis 13 8 (2002) 657-670
34. Esmon C.T. The protein C pathway. Chest 124 3 Suppl (2003) 26S-32S
35. Bick R.L. Hereditary and acquired thrombophilic disorders. Clin Appl Thromb Hemost 12 2 (2006) 125-135
36. Medcalf R.L. Fibrinolysis, inflammation, and regulation of the plasminogen activating system. J Thromb Haemost 5 Suppl 1 (Jul 2007) 132-142
37. Song K.S., Kim Y.A., Kim H.K., et al. Incidence and possible reasons for discordant results between positive FDP and negative D-dimer latex assays in clinical specimens. Yonsei Med J 40 2 (1999) 107-111
38. Kushimoto S., Shibata Y., and Yamamoto Y. Implications of fibrinogenolysis in patients with closed head injury. J Neurotrauma 20 4 (2003) 357-363
39. Collatos C., Barton M.H., and Moore J.N. Fibrinolytic activity in plasma from horses with gastrointestinal diseases: changes associated with diagnosis, surgery, and outcome. J Vet Intern Med 9 1 (1995) 18-23
40. Cattaneo M. Inherited platelet-based bleeding disorders. J Thromb Haemost 1 7 (2003) 1628-1636
41. Christopherson P.W., van Santen V.L., Livesey L., et al. A 10-base-pair deletion in the gene encoding platelet glycoprotein IIb associated with Glanzmann thrombasthenia in a horse. J Vet Intern Med 21 1 (2007) 196-198
42. Macieira S., Rivard G.E., Champagne J., et al. Glanzmann thrombasthenia in an Oldenbourg filly. Vet Clin Pathol 36 2 (2007) 204-208
43. Brooks M. von Willebrand disease. In: Feldman B.F., Zinkl J.G., and Jain N.C. (Eds). Schalm's veterinary hematology (2000), Lippincott Williams Wilkins, Philadelphia 509-515
44. Rathgeber R.A., Brooks M.B., Bain F.T., et al. Clinical vignette. von Willebrand disease in a thoroughbred mare and foal. J Vet Intern Med 15 1 (2001) 63-66
45. Littlewood J.D., Bevan S.A., and Corke M.J. Haemophilia A (classic haemophilia, factor VIII deficiency) in a thoroughbred colt foal. Equine Vet J 23 1 (1991) 70-72
46. Henninger R.W. Hemophilia A in two related quarter horse colts. J Am Vet Med Assoc 193 1 (1988) 91-94
47. Mills J.N., and Bolton J.R. Haemophilia A in a 3-year-old thoroughbred horse. Aust Vet J 60 2 (1983) 63-64
48. Archer R.K., and Allen B.V. True haemophilia in horses. Vet Rec 91 26 (1972) 655-656
49. Goodeve A.C. Laboratory methods for the genetic diagnosis of bleeding disorders. Clin Lab Haematol 20 (1998) 3-19
50. Ljung R., and Tedgard U. Genetic counseling of hemophilia carriers. Semin Thromb Hemost 29 1 (2003) 31-36
51. Castaldo G., D'Argenio V., Nardiello P., et al. Haemophilia A: molecular insights. Clin Chem Lab Med 45 4 (2007) 450-461
52. Furie B., and Furie B. Molecular basis of hemophilia. Semin Hematol 27 (1990) 270-285
53. Thompson A.R. Molecular biology of the hemophilias. In: Coller B.S. (Ed). Progress in hemostasis and thrombosis (1991), W.B. Saunders, Philadelphia 175-214
54. Hinton M., Jones D.R., Lewis I.M., et al. A clotting defect in an Arab colt foal. Equine Vet J 9 1 (1977) 1-3
55. Brooks M.B. A review of canine inherited bleeding disorders: biochemical and molecular strategies for disease characterization and carrier detection. Journal of Heredity 90 (1999) 112-118
56. Geor R.J., Jackson M.L., Lewis K.D., et al. Prekallikrein deficiency in a family of Belgian horses. J Am Vet Med Assoc 197 6 (1990) 741-745
57. Turrentine M.A., Sculley P.W., Green E.M., et al. Prekallikrein deficiency in a family of miniature horses. Am J Vet Res 47 11 (1986) 2464-2467
58. Crawford T.B., Wardrop K.J., Tornquist S.J., et al. A primary production deficit in the thrombocytopenia of equine infectious anemia. J Virol 70 11 (1996) 7842-7850
59. Zimmerman K.L. Drug-induced thrombocytopenias. In: Feldman B.F., Zinkl J.G., and Jain N.C. (Eds). Schalm's veterinary hematology (2000), Lippincott Williams Wilkins, Philadelphia 472-477
60. Preziosi D.E., and Cohn L.A. The increasingly complicated story of Ehrlichia. Compendium 24 (2002) 277-289
61. Sellon D.C., Levine J., Millikin E., et al. Thrombocytopenia in horses: 35 cases (1989-1994). J Vet Intern Med 10 3 (1996) 127-132
62. Byars T.D., and Greene C.E. Idiopathic thrombocytopenic purpura in the horse. J Am Vet Med Assoc 180 12 (1982) 1422-1424
63. McGurrin M.K., Arroyo L.G., and Bienzle D. Flow cytometric detection of platelet-bound antibody in three horses with immune-mediated thrombocytopenia. J Am Vet Med Assoc 224 1 (2004) 83-87 53
64. Buechner-Maxwell V., Scott M.A., Godber L., et al. Neonatal alloimmune thrombocytopenia in a quarter horse foal. J Vet Intern Med 11 5 (1997) 304-308
65. Ramirez S., Gaunt S.D., McClure J.J., et al. Detection and effects on platelet function of anti-platelet antibody in mule foals with experimentally induced neonatal alloimmune thrombocytopenia. J Vet Intern Med 13 6 (1999) 534-539
66. Segura D., Monreal L., Perez-Pujol S., et al. Effects of etamsylate on equine platelets: in vitro and in vivo studies. Vet J 174 2 (2007) 325-329
67. Heidmann P., Tornquist S.J., Qu A., et al. Laboratory measures of hemostasis and fibrinolysis after intravenous administration of epsilon-aminocaproic acid in clinically normal horses and ponies. Am J Vet Res 66 2 (2005) 313-318
68. Elliott J., Berhane Y., and Bailey S.R. Effects of monoamines formed in the cecum of horses on equine digital blood vessels and platelets. Am J Vet Res 64 9 (2003) 1124-1131
69. Mateos-Trigos G., Evans R.J., and Heath M.F. Effects of a P2Y(12) receptor antagonist on the response of equine platelets to ADP. Comparison with human platelets. Res Vet Sci 73 2 (2002) 171-175
70. Kingston J.K., Bayly W.M., Sellon D.C., et al. Effects of sodium citrate, low molecular weight heparin, and prostaglandin E1 on aggregation, fibrinogen binding, and enumeration of equine platelets. Am J Vet Res 62 4 (2001) 547-554
71. Kingston J.K., Sampson S.N., Beard L.A., et al. The effect of supramaximal exercise on equine platelet function. Equine Vet J Suppl 30 (1999) 181-183
72. Shen Y.M., and Frenkel E.P. Acquired platelet dysfunction. Hematol Oncol Clin North Am 21 4 (2007) 647-661 vi
73. Weiss D.J., and Evanson O.A. Comparison of three arginine-glycine-aspartate-containing peptides as inhibitors of equine platelet aggregation. J Vet Pharmacol Ther 27 5 (2004) 377-379
74. Rickards K.J., Andrews M.J., Waterworth T.H., et al. Differential effects of phosphodiesterase inhibitors on platelet activating factor (PAF)- and adenosine diphosphate (ADP)-induced equine platelet aggregation. J Vet Pharmacol Ther 26 4 (2003) 277-282
75. McKenna R. Abnormal coagulation in the postoperative period contributing to excessive bleeding. Med Clin North Am 85 5 (2001) 1277-1310 viii
76. Teitel J.M. Clinical approach to the patient with unexpected bleeding. Clin Lab Haematol 22 Suppl 1 (2000) 9-11 [discussion: 30-2]
77. Tripodi A., and Mannucci P.M. Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research. J Hepatol 46 4 (2007) 727-733
78. Lisman T., and Leebeek F.W. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg 24 4 (2007) 250-258
79. Mount M.E., Feldman B.F., and Buffington T. Vitamin K and its therapeutic importance. J Am Vet Med Assoc 180 11 (1982) 1354-1356
80. Ayala I., Rodriguez M.J., Martos N., et al. Fatal brodifacoum poisoning in a pony. Can Vet J 48 6 (2007) 627-629
81. Scott E.A., Sandler G.A., and Byars T.D. Warfarin: effects on anticoagulant, hematologic, and blood enzyme values in normal ponies. Am J Vet Res 40 1 (1979) 142-146
82. McConnico R.S., Copedge K., and Bischoff K.L. Brodifacoum toxicosis in two horses. J Am Vet Med Assoc 211 7 (1997) 882-886
83. Kirby R., and Rudloff E. Acquired coagulopathy VI: disseminated intravascular coagulation. In: Feldman B.F., Zinkl J.G., and Jain N.C. (Eds). Schalm's veterinary hematology vol. 5 (2000), Lippincott, Williams & Williams, Philadelphia 581-587
84. Ten Cate H. Pathophysiology of disseminated intravascular coagulation in sepsis. Crit Care Med 28 9 (2000) S9-S11
85. Saba H.I., and Morelli G.A. The pathogenesis and management of disseminated intravascular coagulation. Clin Adv Hematol Oncol 4 12 (2006) 919-926
86. Voves C., Wuillemin W.A., and Zeerleder S. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients. Blood Coagul Fibrinolysis 17 6 (2006) 445-451
87. Lee J.H., Song J.W., and Song K.S. Diagnosis of overt disseminated intravascular coagulation: a comparative study using criteria from the International Society versus the Korean Society on Thrombosis and Hemostasis. Yonsei Med J 48 4 (2007) 595-600
88. de Jonge E., van der Poll T., Kesecioglu J., et al. Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience. Semin Thromb Hemost 27 6 (2001) 667-674
89. Kidd L.B., and Darien B.J. The complexities of heparin use for disseminated intravascular coagulation. Vet Forum (2002) 40-47